Description
BSE announces the withdrawal of the public issue by Phytochem Remedies India Limited.
Summary
BSE India has issued a circular regarding the withdrawal of the public issue of Phytochem Remedies India Limited. The company has decided to withdraw its public offering that was scheduled to be listed on the BSE platform.
Key Points
- Phytochem Remedies India Limited has withdrawn its public issue
- The withdrawal is effective as per the circular date
- Investors who had applied for the issue will receive refunds as per applicable regulations
- The company will not proceed with the listing on BSE at this time
Regulatory Changes
No regulatory changes are introduced by this circular. This is a notification of a corporate action (IPO withdrawal).
Compliance Requirements
- The company must ensure proper refund procedures are followed for all applicants
- Refunds must be processed within the timelines specified by SEBI regulations
- All intermediaries involved in the public issue must complete necessary compliance procedures
Important Dates
- Circular Date: December 22, 2025
- Refund timelines to be as per SEBI IPO regulations
Impact Assessment
Market Impact: Medium - The withdrawal affects potential investors who were interested in participating in the public issue. No impact on existing market operations.
Investor Impact: Medium - Applicants will receive refunds, but the withdrawal removes an investment opportunity from the primary market.
Operational Impact: Low - Standard withdrawal procedures to be followed by registrars and intermediaries.
Impact Justification
Public issue withdrawal affects potential investors and market participants who were tracking this IPO